KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Net Income towards Common Stockholders: 2013-2025

Historic Net Income towards Common Stockholders for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $1.7 million.

  • CareDx's Net Income towards Common Stockholders rose 115.75% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.4 million, marking a year-over-year increase of 145.95%. This contributed to the annual value of $52.5 million for FY2024, which is 127.62% up from last year.
  • Per CareDx's latest filing, its Net Income towards Common Stockholders stood at $1.7 million for Q3 2025, which was up 119.55% from -$8.6 million recorded in Q2 2025.
  • CareDx's Net Income towards Common Stockholders' 5-year high stood at $87.7 million during Q4 2024, with a 5-year trough of -$118.1 million in Q4 2023.
  • In the last 3 years, CareDx's Net Income towards Common Stockholders had a median value of -$10.6 million in 2024 and averaged -$14.1 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 2,922.77% in 2022, then spiked by 174.26% in 2024.
  • Quarterly analysis of 5 years shows CareDx's Net Income towards Common Stockholders stood at -$16.2 million in 2021, then declined by 13.49% to -$18.3 million in 2022, then tumbled by 544.32% to -$118.1 million in 2023, then skyrocketed by 174.26% to $87.7 million in 2024, then spiked by 115.75% to $1.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at $1.7 million for Q3 2025, versus -$8.6 million for Q2 2025 and -$10.4 million for Q1 2025.